Boditech Med Statistics
Total Valuation
Boditech Med has a market cap or net worth of KRW 294.73 billion. The enterprise value is 290.81 billion.
| Market Cap | 294.73B |
| Enterprise Value | 290.81B |
Important Dates
The last earnings date was Wednesday, November 12, 2025.
| Earnings Date | Nov 12, 2025 |
| Ex-Dividend Date | Mar 31, 2025 |
Share Statistics
Boditech Med has 21.78 million shares outstanding. The number of shares has decreased by -0.94% in one year.
| Current Share Class | 21.78M |
| Shares Outstanding | 21.78M |
| Shares Change (YoY) | -0.94% |
| Shares Change (QoQ) | -0.34% |
| Owned by Insiders (%) | 39.17% |
| Owned by Institutions (%) | 1.19% |
| Float | 13.13M |
Valuation Ratios
The trailing PE ratio is 10.82.
| PE Ratio | 10.82 |
| Forward PE | n/a |
| PS Ratio | 1.94 |
| PB Ratio | 1.24 |
| P/TBV Ratio | 1.35 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | 14.20 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 7.75, with an EV/FCF ratio of -25.16.
| EV / Earnings | 10.68 |
| EV / Sales | 1.92 |
| EV / EBITDA | 7.75 |
| EV / EBIT | 10.44 |
| EV / FCF | -25.16 |
Financial Position
The company has a current ratio of 5.05, with a Debt / Equity ratio of 0.07.
| Current Ratio | 5.05 |
| Quick Ratio | 3.20 |
| Debt / Equity | 0.07 |
| Debt / EBITDA | 0.49 |
| Debt / FCF | -1.52 |
| Interest Coverage | 77.88 |
Financial Efficiency
Return on equity (ROE) is 11.89% and return on invested capital (ROIC) is 6.73%.
| Return on Equity (ROE) | 11.89% |
| Return on Assets (ROA) | 6.25% |
| Return on Invested Capital (ROIC) | 6.73% |
| Return on Capital Employed (ROCE) | 10.39% |
| Revenue Per Employee | 280.50M |
| Profits Per Employee | 50.33M |
| Employee Count | 541 |
| Asset Turnover | 0.58 |
| Inventory Turnover | 1.69 |
Taxes
In the past 12 months, Boditech Med has paid 4.98 billion in taxes.
| Income Tax | 4.98B |
| Effective Tax Rate | 15.41% |
Stock Price Statistics
The stock price has decreased by -18.20% in the last 52 weeks. The beta is 0.23, so Boditech Med's price volatility has been lower than the market average.
| Beta (5Y) | 0.23 |
| 52-Week Price Change | -18.20% |
| 50-Day Moving Average | 13,761.00 |
| 200-Day Moving Average | 14,802.55 |
| Relative Strength Index (RSI) | 48.18 |
| Average Volume (20 Days) | 45,870 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Boditech Med had revenue of KRW 151.75 billion and earned 27.23 billion in profits. Earnings per share was 1,250.08.
| Revenue | 151.75B |
| Gross Profit | 87.92B |
| Operating Income | 26.04B |
| Pretax Income | 32.34B |
| Net Income | 27.23B |
| EBITDA | 35.71B |
| EBIT | 26.04B |
| Earnings Per Share (EPS) | 1,250.08 |
Balance Sheet
The company has 35.00 billion in cash and 17.52 billion in debt, giving a net cash position of 17.48 billion or 802.36 per share.
| Cash & Cash Equivalents | 35.00B |
| Total Debt | 17.52B |
| Net Cash | 17.48B |
| Net Cash Per Share | 802.36 |
| Equity (Book Value) | 237.02B |
| Book Value Per Share | 10,295.32 |
| Working Capital | 97.25B |
Cash Flow
In the last 12 months, operating cash flow was 20.76 billion and capital expenditures -32.32 billion, giving a free cash flow of -11.56 billion.
| Operating Cash Flow | 20.76B |
| Capital Expenditures | -32.32B |
| Free Cash Flow | -11.56B |
| FCF Per Share | -530.51 |
Margins
Gross margin is 57.94%, with operating and profit margins of 17.16% and 17.94%.
| Gross Margin | 57.94% |
| Operating Margin | 17.16% |
| Pretax Margin | 21.31% |
| Profit Margin | 17.94% |
| EBITDA Margin | 23.53% |
| EBIT Margin | 17.16% |
| FCF Margin | n/a |
Dividends & Yields
This stock pays an annual dividend of 150.00, which amounts to a dividend yield of 1.11%.
| Dividend Per Share | 150.00 |
| Dividend Yield | 1.11% |
| Dividend Growth (YoY) | -25.00% |
| Years of Dividend Growth | 1 |
| Payout Ratio | 12.00% |
| Buyback Yield | 0.94% |
| Shareholder Yield | 2.06% |
| Earnings Yield | 9.24% |
| FCF Yield | -3.92% |
Stock Splits
The last stock split was on April 5, 2017. It was a forward split with a ratio of 1.1.
| Last Split Date | Apr 5, 2017 |
| Split Type | Forward |
| Split Ratio | 1.1 |
Scores
Boditech Med has an Altman Z-Score of 7.73 and a Piotroski F-Score of 3.
| Altman Z-Score | 7.73 |
| Piotroski F-Score | 3 |